-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
BG-12 (dimethyl fumarate) in the treatment of multiple sclerosis
Oscar Fernandez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
Surrogate end points: when should they be used?
Geert Molenberghs, Ariel Alonso Abad, Wim van der Elst, Tomasz Burzykowski, Marc Buyse
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
An update of adjuvant treatments for localized advanced gastric cancer
Yoon-Koo Kang
Review Article: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation
-
Diffuse large B-cell lymphoma: update on therapy and prognosis
Manuel Gotti, Valeria Fiaccadori, Ercole Brusamolino
Review Article: Clinical Investigation